Open access
snoRNAs: New players in CKD biomarkers
Medicine
Abstract
It is a clinical unmet need to identify novel biomarkers to improve diagnosis, prediction and prognosis, as well as response and pharmacodynamics of established and novel therapeutic interventions. Chronic kidney disease